| #402 |
Liying Shen |
Meta |
1 |
| #402 |
Nicholas Halpern |
Block |
1 |
| #402 |
Stuart Pomerantz |
GE |
1 |
| #402 |
Anthony Maglio |
Sonos |
1 |
| #402 |
Tomás Pluskal |
Whitehead Institute For Biomedical Research |
1 |
| #402 |
Marin Vulic |
Seres Therapeutics |
1 |
| #402 |
Jonathan Winkler |
Seres Therapeutics |
1 |
| #402 |
Jose Marvin Xuya Orozco |
Whitehead Institute For Biomedical Research |
1 |
| #402 |
Sydney M. Rice |
Kpmg Llp |
1 |
| #402 |
Ruth M. Ruprecht |
Dana-Farber Cancer Institute |
1 |
| #402 |
Marjon Zamani |
CNRS |
1 |
| #402 |
Thomas Jay Leonard |
Microsoft |
1 |
| #402 |
Joseph Shea |
Srl |
1 |
| #402 |
Daniel Kunkle |
Google |
1 |
| #402 |
Jim Dolan |
Sonos |
1 |
| #402 |
Tanya Rudakevych |
IBM |
1 |
| #402 |
Junichi Tokuda |
Brigham and Women's Hospital |
1 |
| #402 |
Melissa B. Lewis |
Mouse Specifics |
1 |
| #402 |
Brian J. Taylor |
Rockwell Automation |
1 |
| #402 |
Jacque Zwahlen |
Vertex Pharmaceuticals Incorporated |
1 |
| #402 |
Jason A. Messier |
Teradyne |
1 |
| #402 |
Zhuangsheng Lin |
Cornell University |
1 |
| #402 |
Matthias Stephan |
Fred Hutchinson Cancer Research Center |
1 |
| #402 |
Christopher P. Hencken |
Alkermes Pharma Ireland Limited |
1 |
| #402 |
Jeremy Achin |
Datarobot |
1 |
| #402 |
Anthony Coyle |
Medimmune Limited |
1 |
| #402 |
Robert Manguso |
Dana-Farber Cancer Institute |
1 |
| #402 |
Marco Ferrara |
Form Energy |
1 |
| #402 |
Daniel B. Lazarchik |
The Procter & Gamble |
1 |
| #402 |
Georgios Dimitrakopoulos |
Intralot S.A.—Integrated Lottery Systems And Services |
1 |
| #402 |
Emery N. Brown |
The General Hospital |
1 |
| #402 |
Sarah Cohen |
X4 Pharmaceuticals |
1 |
| #402 |
Samantha J. Pulliam |
Renovia |
1 |
| #402 |
Christopher K. Oto |
Boston Scientific Scimed |
1 |
| #402 |
Weiwei Chen |
Xiaomi |
1 |
| #402 |
Christopher John Sibbald Deane |
Fastcap Systems |
1 |
| #402 |
Donna Roy Grogan |
Clementia Pharmaceuticals |
1 |
| #402 |
Fernanda H. Sakamoto |
The General Hospital |
1 |
| #402 |
Brian Chang |
Abiomed |
1 |
| #402 |
Kirsten Lewis |
Sonos |
1 |
| #402 |
Robin Y. Smith |
Perkinelmer Informatics |
1 |
| #402 |
Paul Haddad |
Csc Holdings |
1 |
| #402 |
Noah Michael Jakimo |
MIT |
1 |
| #402 |
Tyler Smith |
Sharkninja Operating |
1 |
| #402 |
Zongli Zheng |
The General Hospital |
1 |
| #402 |
Kiran Reddy |
Praxis Precision Medicines |
1 |
| #402 |
Michael J. Gambuzza |
Littelfuse |
1 |
| #402 |
Navreet Dhindsa |
Ipsen Biopharm Limited |
1 |
| #402 |
Ulises Hernando Bautista |
The Gillette Company |
1 |
| #402 |
Guy Bemis |
Vertex Pharmaceuticals Incorporated |
1 |